Fructose Metabolism (Fructolysis)
- Compartment
- Cytosol
- Main tissue
- Liver (mainly), kidney, small intestine
- Rate-limiting
- Aldolase B (fructose-1-phosphate aldolase)
- Steps
- 5
Reaction steps
In source order, 5 total
-
1
Fructose + ATP → fructose-1-phosphate + ADP
› Notes
Hepatic fructokinase (ketohexokinase) uses ATP and Mg2+ to phosphorylate fructose at carbon 1. This reaction is effectively irreversible and has high capacity but is not tightly feedback-regulated; rapid flux can transiently consume ATP and phosphate when fructose intake is very high.
-
2
Fructose-1-phosphate → dihydroxyacetone phosphate + glyceraldehyde
› Notes
Aldolase B (fructose-1-phosphate aldolase) cleaves fructose-1-phosphate without a redox cofactor. This is the defining hepatic fructolysis cleavage reaction and is functionally the pathway's critical/committed processing step because failure traps phosphate as fructose-1-phosphate.
-
3
Glyceraldehyde + ATP → glyceraldehyde-3-phosphate + ADP
› Notes
Triokinase (glyceraldehyde kinase) requires ATP and Mg2+, phosphorylating glyceraldehyde. Glyceraldehyde-3-phosphate and dihydroxyacetone phosphate can then enter glycolysis, gluconeogenesis, glycerol-3-phosphate synthesis, or lipogenesis.
-
4
Dihydroxyacetone phosphate ↔ glyceraldehyde-3-phosphate
› Notes
Triose phosphate isomerase reversibly interconverts the products of fructolysis as needed for downstream glycolysis or gluconeogenesis. No additional ATP or redox cofactor is used.
-
5
Alternative extrahepatic entry: fructose + ATP → fructose-6-phosphate + ADP
› Notes
Hexokinase can phosphorylate fructose at carbon 6 using ATP and Mg2+, yielding fructose-6-phosphate for entry upstream of PFK-1. This route is generally minor because hexokinase preferentially phosphorylates glucose and because liver fructokinase efficiently clears portal fructose.
Showing all 5 steps.
Regulation
What speeds each enzyme up and what slows it down
Fructokinase (ketohexokinase)
Substrate availability
No important physiological allosteric inhibitor
No dominant acute hormonal control; hepatic flux depends largely on fructose delivery
Aldolase B
Substrate availability
Product accumulation; loss of activity causes fructose-1-phosphate trapping
No major acute hormonal control
Triokinase
Substrate availability
No well-established major physiological allosteric inhibitor
No major acute hormonal control
Overview
Fructose is absorbed from the intestine and is metabolized chiefly in the liver by a pathway that converts it to triose phosphates. Hepatic fructolysis bypasses PFK-1, allowing rapid carbon entry downstream of glycolysis's principal regulatory step. Extrahepatic tissues can phosphorylate fructose through hexokinase, but this route is usually quantitatively minor at physiological fructose concentrations.
Cellular location
The principal fructolysis reactions occur in the cytosol of hepatocytes; kidney cortex and small-intestinal mucosa also express fructokinase and aldolase B. Fructose enters enterocytes mainly through GLUT5 and exits toward portal blood through GLUT2; hepatic uptake is mediated largely by GLUT2. The alternative hexokinase route is cytosolic in muscle, adipose tissue, and other cells.
Net energetics
Conversion of one fructose to two triose phosphates through the liver-specific pathway consumes 2 ATP (one each at fructokinase and triokinase) and produces no NADH, NADPH, FADH2, or GTP in the entry reactions. If both trioses proceed through glycolysis to pyruvate, the downstream payoff is the same as for two glyceraldehyde-3-phosphate molecules: 4 ATP and 2 NADH, giving net 2 ATP and 2 NADH per fructose from fructose to two pyruvate. The bypass of PFK-1 changes regulation, not the overall glycolytic ATP accounting.
Clinical significance
Because hepatic fructolysis supplies trioses below PFK-1, high fructose flux can favor hepatic glycerol-3-phosphate formation, de novo lipogenesis, and triacylglycerol synthesis when energy intake is excessive. Essential fructosuria results from fructokinase deficiency and is typically benign because fructose is excreted or metabolized by alternative pathways. Hereditary fructose intolerance, caused by aldolase B deficiency, produces fructose-1-phosphate accumulation, phosphate/ATP depletion, inhibition of glycogenolysis and gluconeogenesis, severe hypoglycemia, vomiting, jaundice, and potential liver failure after fructose, sucrose, or sorbitol ingestion.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
Transposon insertion sequencing identifies novel genes involved in product synthesis in gas-fermenting <i>Clostridium ljungdahlii</i>.
Zhang Z, Yang F, Liu Y, Ye W, Jia D, Tian Y, Jiang W, Wang Q, Gu Y. · 2026-05-09
open access unreviewed -
2
Overconsumption of fructose aggravates acute GVHD by inducing gut dysbiosis and promoting macrophage-mediated inflammatory response.
Wu K, Yu H, Cao K, Dai B, Yuan Y, Qian X, Zhong H, Qu Y, Jiang H, Chen T. · 2026-03-13
open access unreviewed -
3
Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation.
Xiao Y, Liu L, Liu S, Wang L, Tian J, Shao Z, Shi J, Cui C. · 2026-03-09
open access unreviewed -
4
Characterization and functional analysis of FruR in Streptomyces lincolnensis: A pleiotropic regulator that links fructose metabolism to lincomycin biosynthesis.
Gao Y, Chen L, Zhang Z, Xu N, Ye J, Wang R, Wu H, Zhang H. · 2026-06-09
unreviewed -
5
Metabolism of fructose in the heart favors glycerate production and is linked to cardiac dysfunction in diabetes.
Annandale M, Lachance D, Robillard IF, Guo G, Li X, Koutsifeli P, Daniels LJ, Zarate E, Grey AC, Delbridge LM… · 2026-08-08
unreviewed -
6
Microbiota-Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma.
AlRamadneh TN, S RJ, Nayak PP, Nanda A, Hasnaawei SA, Bhatt A, Chauhan AS, Singla S, Nourizadeh M. · 2026-08-01
unreviewed -
7
Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.
Zhang H, Zhu Y, Xu C. · 2026-06-30
unreviewed -
8
Metabolomics and transcriptomics analyses reveal the synthetic pathway of sweet substances in the bamboo shoots of Dendrocalamus brandisii.
Ma Y, Wang Y, Wang H, Ma Y, Zhan H, Li Y, Wang S, Li J. · 2026-06-25
unreviewed -
9
On the Origin of the Brain Semi-Heavy Water Deuterium MR Signal Following Administration of Deuterated Metabolic Substrate: A Cautionary Tale.
Ackerman JJH, Ge X, Rensing N, Neil JJ, Thio LL, Garbow JR. · 2026-03-24
open access unreviewed -
10
Endogenous fructose production in patients and mice with aldolase B deficiency.
Buziau AM, Simons N, Tolan DR, Caiment F, Scheijen JLJM, van de Waarenburg MP, Schalkwijk CG, Brouwers MCGJ. · 2026-07-17
unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.